05:44 PM EST, 01/07/2025 (MT Newswires) -- Sight Sciences ( SGHT ) said late Tuesday that a 36-month study evaluating the long-term effectiveness of its OMNI Surgical System in treating primary open-angle glaucoma demonstrated sustained reductions in intraocular pressure and medication use.

Mean intraocular pressure reductions ranged from 5.6 mmHg to 7.1 mmHg with greater declines in patients with higher baseline, the company said.

The results show significant decreases in utilization of medications through 18 months postoperatively, the company added.

The study evaluated 230 eyes of 196 patients with primary open-angle glaucoma.

Shares of the company were up 1.5% in recent after-hours activity.

Price: 3.36, Change: +0.05, Percent Change: +1.51